FI93447B - Analogiförfarande för framställning av terapeutiskt användbara 3-(tetrahydropyrido-, dihydropyrrolo- och tetrahydropyrazino/1,2-a/indol-10-yl)pyrrol-2,5-dionderivat - Google Patents

Analogiförfarande för framställning av terapeutiskt användbara 3-(tetrahydropyrido-, dihydropyrrolo- och tetrahydropyrazino/1,2-a/indol-10-yl)pyrrol-2,5-dionderivat

Info

Publication number
FI93447B
FI93447B FI900863A FI900863A FI93447B FI 93447 B FI93447 B FI 93447B FI 900863 A FI900863 A FI 900863A FI 900863 A FI900863 A FI 900863A FI 93447 B FI93447 B FI 93447B
Authority
FI
Finland
Prior art keywords
pyrrole
tetrahydropyrazino
dihydropyrrolo
tetrahydropyrido
indol
Prior art date
Application number
FI900863A
Other languages
English (en)
Finnish (fi)
Other versions
FI93447C (sv
FI900863A0 (sv
Inventor
Peter David Davis
Christopher Huw Hill
Geoffrey Lawton
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898904161A external-priority patent/GB8904161D0/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI900863A0 publication Critical patent/FI900863A0/sv
Application granted granted Critical
Publication of FI93447B publication Critical patent/FI93447B/sv
Publication of FI93447C publication Critical patent/FI93447C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
FI900863A 1989-02-23 1990-02-21 Analogiförfarande för framställning av terapeutiskt användbara 3-(tetrahydropyrido-, dihydropyrrolo- och tetrahydropyrazino/1,2-a/indol-10-yl)pyrrol-2,5-dionderivat FI93447C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8904161 1989-02-23
GB898904161A GB8904161D0 (en) 1989-02-23 1989-02-23 Substituted pyrroles
GB8928210 1989-12-13
GB898928210A GB8928210D0 (en) 1989-02-23 1989-12-13 Substituted pyrroles

Publications (3)

Publication Number Publication Date
FI900863A0 FI900863A0 (sv) 1990-02-21
FI93447B true FI93447B (sv) 1994-12-30
FI93447C FI93447C (sv) 1995-04-10

Family

ID=26295005

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900863A FI93447C (sv) 1989-02-23 1990-02-21 Analogiförfarande för framställning av terapeutiskt användbara 3-(tetrahydropyrido-, dihydropyrrolo- och tetrahydropyrazino/1,2-a/indol-10-yl)pyrrol-2,5-dionderivat

Country Status (20)

Country Link
EP (1) EP0384349B1 (sv)
JP (1) JPH06102661B2 (sv)
AT (1) ATE104972T1 (sv)
AU (1) AU633051B2 (sv)
CA (1) CA2010636C (sv)
CZ (1) CZ284587B6 (sv)
DE (1) DE59005491D1 (sv)
DK (1) DK0384349T3 (sv)
DZ (1) DZ1399A1 (sv)
ES (1) ES2052995T3 (sv)
FI (1) FI93447C (sv)
HU (1) HU206351B (sv)
IE (1) IE64184B1 (sv)
IL (1) IL93433A (sv)
MC (1) MC2096A1 (sv)
NO (1) NO174891C (sv)
NZ (1) NZ232589A (sv)
PT (1) PT93246B (sv)
RU (2) RU2014332C1 (sv)
SK (1) SK85590A3 (sv)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles
DE4128015A1 (de) * 1991-08-23 1993-02-25 Kali Chemie Pharma Gmbh 1,7-anellierte 2-(piperazinoalkyl)indol-derivate sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindugnen enthaltende arzneimittel
GB9123396D0 (en) * 1991-11-04 1991-12-18 Hoffmann La Roche A process for the manufacture of substituted maleimides
EP0630241A1 (en) * 1992-03-20 1994-12-28 The Wellcome Foundation Limited Indole derivatives with antiviral activity
AU678435B2 (en) * 1993-05-10 1997-05-29 F. Hoffmann-La Roche Ag Substituted pyrroles
US5721230A (en) * 1993-05-10 1998-02-24 Hoffmann-La Roche Inc. Substituted pyrroles
US5405864A (en) * 1993-10-15 1995-04-11 Syntex (U.S.A.) Inc. Chemotherapeutic maleimides
US5541347A (en) * 1993-12-07 1996-07-30 Eli Lilly And Company Synthesis of bisindolylmaleimides
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
FI945705A (sv) * 1993-12-07 1996-06-03 Lilly Co Eli Förbättrad syntes av bisindolylmaleimider
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
ATE204579T1 (de) * 1993-12-07 2001-09-15 Lilly Co Eli Proteinkinase c-inhibitoren
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
ATE290378T1 (de) 1993-12-23 2005-03-15 Lilly Co Eli Proteinkinase c-inhibitoren
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
ES2123873T3 (es) * 1994-08-04 1999-01-16 Hoffmann La Roche Pirrolocarbazol.
US5594009A (en) * 1994-10-14 1997-01-14 Cephalon, Inc. Fused pyrrolocarbazoles
US5591855A (en) * 1994-10-14 1997-01-07 Cephalon, Inc. Fused pyrrolocarbazoles
US5705511A (en) * 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
US5475110A (en) * 1994-10-14 1995-12-12 Cephalon, Inc. Fused Pyrrolocarbazoles
CA2207404C (en) * 1994-12-13 2004-06-29 F. Hoffmann-La Roche Ag Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
US5616724A (en) * 1996-02-21 1997-04-01 Cephalon, Inc. Fused pyrrolo[2,3-c]carbazole-6-ones
CA2268399C (en) * 1996-10-31 2008-08-19 Harbor Branch Oceanographic Institution, Inc. Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
WO2001013916A1 (fr) * 1999-08-20 2001-03-01 Sagami Chemical Research Center Medicaments inhibant la mort cellulaire
DE60107857T2 (de) 2000-07-27 2005-12-08 F. Hoffmann-La Roche Ag 3-Indolyl-4-Phenyl-1H-Pyrrol-2,5-Dion-Derivate als Glycogen Synthase-Kinase 3Beta Inhibitoren
US6849643B2 (en) 2000-12-08 2005-02-01 Ortho-Mcneil Pharmaceutical, Inc. Indazolyl-substituted pyrroline compounds as kinase inhibitors
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
CN100536850C (zh) 2003-08-08 2009-09-09 诺瓦提斯公司 包含星孢素的组合
US7691861B2 (en) * 2004-01-19 2010-04-06 Novartis Ag Indolymaleimide derivatives
EP1819697B1 (en) 2004-12-08 2012-08-01 Johannes Gutenberg-Universität Mainz 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
RU2547148C2 (ru) 2005-02-09 2015-04-10 Аркьюл, Инк. Композиции и способы лечения рака
WO2007006533A2 (en) 2005-07-11 2007-01-18 Novartis Ag Indolylmaleimide derivatives
ES2443022T3 (es) * 2005-08-12 2014-02-17 Merck Frosst Canada Inc. Derivados de indol como antagonistas del receptor CRTH2
EP1980561B1 (en) 2007-03-30 2013-10-09 Nerviano Medical Sciences S.R.L. Substituted 1h-pyrazolo[3,4-b] pyridine derivatives active as kinase inhibitors
JP5425060B2 (ja) * 2007-06-22 2014-02-26 アークル インコーポレイテッド ピロリジノン、ピロリジン−２，５−ジオン、ピロリジンおよびチオスクシンイミド誘導体、癌の治療のための組成物および方法
JP2010530885A (ja) 2007-06-22 2010-09-16 アークル インコーポレイテッド キナゾリノン化合物およびその使用方法
EP2173748B1 (en) 2007-06-22 2011-08-31 ArQule, Inc. Indolyl pyrrolidines for the treatment of cancer
EP2346865B1 (en) 2008-09-22 2015-07-15 Merck Canada Inc. Indole derivatives as crth2 receptor antagonists
EP2343291A1 (en) 2009-12-18 2011-07-13 Johannes Gutenberg-Universität Mainz 3-(Indolyl)- or 3-(Azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
WO2011082266A2 (en) 2009-12-30 2011-07-07 Arqule, Inc. Substituted heterocyclic compounds
EP2474541A1 (en) 2010-12-23 2012-07-11 Johannes- Gutenberg-Universität Mainz Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
EP2989104B1 (en) * 2013-04-23 2019-08-21 Esteve Pharmaceuticals, S.A. Pyrazino[1,2-a]indole compounds, their preparation and use in medicaments
JP2017524739A (ja) 2014-07-17 2017-08-31 アンセルムＩｎｓｅｒｍ 神経筋接合部関連疾患の処置方法
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
EP3187495A1 (en) 2015-12-30 2017-07-05 Johannes Gutenberg-Universität Mainz 3-(5-fluoroindolyl)-4-arylmaleimide compounds and their use in tumor treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
US5049563A (en) * 1988-07-07 1991-09-17 Duphar International Research B.V. Annelated indoleketones with an imidazolylalkyl substituent

Also Published As

Publication number Publication date
HU900846D0 (en) 1990-04-28
EP0384349B1 (de) 1994-04-27
NO174891B (no) 1994-04-18
CZ284587B6 (cs) 1999-01-13
JPH02264776A (ja) 1990-10-29
CZ85590A3 (cs) 1998-10-14
DZ1399A1 (fr) 2004-09-13
SK278711B6 (sk) 1998-01-14
HUT53369A (en) 1990-10-28
NO900855D0 (no) 1990-02-22
IE64184B1 (en) 1995-07-12
AU633051B2 (en) 1993-01-21
RU2014332C1 (ru) 1994-06-15
NO900855L (no) 1990-08-24
ATE104972T1 (de) 1994-05-15
AU5003390A (en) 1990-08-30
IL93433A0 (en) 1990-11-29
DE59005491D1 (de) 1994-06-01
PT93246B (pt) 1996-01-31
MC2096A1 (fr) 1991-02-15
JPH06102661B2 (ja) 1994-12-14
ES2052995T3 (es) 1994-07-16
SK85590A3 (en) 1998-01-14
EP0384349A1 (de) 1990-08-29
IL93433A (en) 1996-11-14
NO174891C (no) 1994-07-27
HU206351B (en) 1992-10-28
IE900647L (en) 1990-08-23
FI93447C (sv) 1995-04-10
RU2142460C1 (ru) 1999-12-10
CA2010636A1 (en) 1990-08-23
PT93246A (pt) 1990-08-31
DK0384349T3 (da) 1994-09-05
FI900863A0 (sv) 1990-02-21
CA2010636C (en) 1999-12-14
NZ232589A (en) 1992-09-25

Similar Documents

Publication Publication Date Title
FI93447B (sv) Analogiförfarande för framställning av terapeutiskt användbara 3-(tetrahydropyrido-, dihydropyrrolo- och tetrahydropyrazino/1,2-a/indol-10-yl)pyrrol-2,5-dionderivat
AU5061190A (en) Novel benzimidazole and azabenzimidazole derivatives, their methods of preparation, synthesis intermediates and pharmaceutical compositions in which they are present and which are useful especially for the treatment of cardiovascular diseases and duodenal ulcers
RU93033479A (ru) Способ получения замещенных пирролов, способ получения фармацевтических препаратов
AU595631B2 (en) 7-((3-(aminomethyl)-3-alkyl)-1-pyrrolidinyl)- quinoline-carboxylic acids
NO175873C (no) Mikrobiell fremgangsmåte for fremstilling av immunhemmende antibiotika
NO20003784L (no) FremgangsmÕte for fremstilling av enansiomert rene cykloalkanoindolkarboksylsyre og azaindolkarboksylsyrer og pyrimido 1,2a indolkarboksylsyrer og derivater derav
AU529996B2 (en) Synthesis of vincaminic acid derivatives
NO984083L (no) Substituerte 3-aryl-3-karboksylalkyl-glutarimider, fremgangsmÕte ved fremstilling av disse ved 4-arylo-4-cyanoheptan-dikarboksylsyrecyklisering, og anvendelse derav for fremstilling av 3-aryl-3-hydroksyalkylpiperidiner
FI912247A0 (sv) Förfarande för framställning av terapeutiskt användbara pyrrolo/2,3-b/indolketonderivat
IE780849L (en) Thienamycin derivatives
HUP0100429A2 (hu) Pirrolo[3,2-b]piridin-származékok, valamint eljárás e vegyületek és ezek közbenső termékeinek előállítására
IS3938A (is) Aðferð við framleiðslu nýrra pyrimídó [1',6':1,2]pyridó [3,4-b] indól afleiða og lyfjablandna sem innihalda þær

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: F. HOFFMANN - LA ROCHE AG

MA Patent expired